LTG-001

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameLTG-001
Drug Alias NameLTG-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit modulators
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsAcute PainPainPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLatigo Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLatigo Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsAcute PainPainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A